To further assess the contribution of bacterial and host-derived DPP4 to intestinal fibrosis in CD, and to evaluate the therapeutic potential of targeting both sources of DPP4, we conducted in vivo experiments using the DSS-induced chronic colitis model. Here, DPP4 is linked to Chronic colitis.